Results

Total Results: 463 records

Showing results for "renal".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
    November 21, 2019 - disease (Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria III or IV), end- stage renal … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage renal … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage renal
  2. effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
    December 29, 2020 - Renal harms were not reported in the trial, likely in part because of the short duration of symptoms … NSAIDs We advocate ensuring that acute kidney injury and other renal issues are included in the adverse … Findings regarding acetaminophen versus opioids for renal colic are based on a large, good-quality … Renal colic. … standard for severe acute pain for centuries, are probably less effective than acetaminophen for renal
  3. effectivehealthcare.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
    July 21, 2014 - Factors such as performance status and renal function must be considered in relation to treatment effectiveness … Medically frail patients may not be good candidates for cisplatin because of potential renal toxicity
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
    September 13, 2012 - Major—renal toxicity, hepatic toxicity, gastrointestinal upset c. … multiple daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Abbreviations: C. diff
  5. effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research-protocol
    June 16, 2010 - Dynepo had been approved in Europe for the treatment of symptomatic anemia associated with chronic renal … platinum-based chemotherapy regimens may diminish endogenous erythropoietin production by damaging renal … important (or adjunctive) analysis to perform, in keeping with some of the data available from the renal
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - transplantation : official publication of the European Dialysis and Transplant Association - European Renal … of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renalRenal failure. 2015;37(7):1080-8. 105. Zafack JG, De Serres G, Kiely M, et al. … Nervous system disorders • Pregnancy, puerperium and perinatal conditions • Psychiatric disorders • Renal
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - Clinically significant comorbidities were more frequent in the group receiving H-ISDN; for example, renal … 39.7% 54 <.0001 Diabetes (complicated) 15.3% 27 <.0001 Hypothyroidism 5.1% 4.2 0.01 Renal
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
    March 01, 2012 - 2) Page ES-15 bullet 11 describes information concerning the effects of some drugs by baseline renal … function subgroup, and there was no evidence that these increases were altered by renal insufficiency … reductions were similar and did not differ significantly between patients with normal or impaired renal … No particular safety issues were identified in subgroups defined by renal function. … Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
    June 05, 2014 - glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal
  10. effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-1/research
    March 30, 2009 - year including solid organ transplantation, HIV/AIDS, cancer-except non-melanoma skin cancers, chronic renal
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-muscle-invasive_research-protocol.pdf
    July 21, 2014 - Factors such as performance status and renal function must be considered in relation to treatment effectiveness … Medically frail patients may not be good candidates for cisplatin because of potential renal toxicity
  12. effectivehealthcare.ahrq.gov/products/infantile-hemangioma/research-protocol
    December 04, 2014 - anomalies, ulceration, myelopathy, bony deformities, anorectal malformations, arterial anomalies, and renal … SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with … urogenital anomalies, ulceration, myelopathy, bony deformities, anorectal malformations, arterial anomalies, renal
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
    January 01, 2012 - One quality C study reported on mortality and end-stage renal disease. … mortality with SMBP plus self- titration versus usual care, and lower composite mortality and end-stage renal … End-stage renal disease alone was not significantly different.
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - Dynepo had been approved in Europe for the treatment of symptomatic anemia associated with chronic renal … platinum-based chemotherapy regimens may diminish endogenous erythropoietin production by damaging renal … important (or adjunctive) analysis to perform, in keeping with some of the data available from the renal
  15. effectivehealthcare.ahrq.gov/products/postpartum-care-one-year/draft-comments
    August 12, 2021 - with chronic medical conditions (e.g. hypertensive disorders, obesity, diabetes, thyroid disorders, renal
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
    September 01, 2012 - Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high … Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal … Failure Due to Myeloma Cast Nephropathy Recruiting Chronic renal failure with uremic nephropathy … Multiple Myeloma (BMT CTN 0702) Recruiting MM 750 NCT00120263 Trial of Plasma Exchange for Acute Renal … Failure at the Onset of Myeloma Completed MM Acute Renal Failure 92 NCT00135187 Study of Combination
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
    April 01, 2014 - versus enema alone or no preparation, only two provided information on harms (1 for nausea and 1 for renal … of 89 patients receiving OMBP versus 1 of 89 patients receiving no preparation experienced acute renalRenal failure, an outcome considered important given that many OMBP strategies involve ingestion of … patients and patients with very compromised function of major systems (e.g., cardiac, pulmonary, renal
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
    December 23, 2014 - anomalies, ulceration, myelopathy, bony deformities, anorectal malformations, arterial anomalies, and renal … SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated … anomalies, ulceration, myelopathy, bony deformities, anorectal malformations, arterial anomalies, renal
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
    January 15, 2015 - • Harms, risks and consequences of testing o Procedural harms, adverse events of testing (e.g., renal … Special populations and circumstances of interest include: • Patients with renal insufficiency, diabetes … Harms, risks and consequences of testing (both initial and subsequent testing) • Harms of testing (renal
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
    June 01, 2011 - of Nature of Reported Process Organizing Principle 1 Australia Caring for Australasians with Renal … only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver outcomes, and renal … (NICU) admissions; liver outcomes (alanine transaminase [ALT], aspartate transaminase [AST]); and renal … Australia Medical Services Advisory Committee MSAC HTA 5 Australia Caring for Australasians with Renal … - 4 Australia Caring for Australasians with Renal Impairment CARI Yes 1999-2000 1.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: